Bruce Phillips
Family Medicine · Dallas, TXNPI 1922121748
Payments from drug & device makers
Across 157 payments — averaging $21.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$519
- Amgen$443
- Novo Nordisk$273
- Takeda Pharmaceuticals U.S.A., Inc.$254
- GSK$249
- AbbVie$200
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,366100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $519 |
| Amgen | 15 | $443 |
| Novo Nordisk | 10 | $273 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $254 |
| GSK | 13 | $249 |
| AbbVie(2 entities) | 13 | $200 |
| Eisai Inc. | 11 | $196 |
| Supernus Pharmaceuticals, Inc. | 6 | $195 |
| Pfizer | 9 | $158 |
| Currax Pharmaceuticals LLC | 9 | $129 |
| Lilly USA, LLC | 9 | $117 |
| Otsuka America Pharmaceutical, Inc. | 5 | $86 |
| Bausch Health US, LLC | 5 | $85 |
| Idorsia Pharmaceuticals US Inc | 4 | $61 |
| Genentech USA, Inc. | 3 | $54 |
| Adlon Therapeutics L.p. | 3 | $51 |
| Cleerly, Inc. | 1 | $42 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| Shire North American Group Inc | 2 | $28 |
| Novartis | 1 | $24 |
| Millicent US Inc | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Dermira, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,366 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 24 | $21,548 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $21,030 |
| MounjaroTirzepatide | 20 | $20,251 |
| FarxigaDapagliflozin Propanediol | 11 | $9,738 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $7,824 |
| Eszopiclone | 59 | $970 |
| SynthroidLevothyroxine Sodium | 18 | $940 |
| Rosuvastatin Calcium | 50 | $736 |
| Atorvastatin Calcium | 68 | $532 |
| Celecoxib | 15 | $403 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $400 |
| Bupropion XlBupropion Hcl | 14 | $397 |
| Pantoprazole Sodium | 31 | $353 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 36 | $342 |
| Testosterone Cypionate | 14 | $340 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $273 | $21,54824 claims |
| GSKTrelegy Ellipta | $249 | $21,03033 claims |
| Lilly USA, LLCMounjaro | $117 | $20,25120 claims |
| AstraZenecaFarxiga | $519 | $9,73811 claims |
| AbbVieSynthroid | $200 | $94018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Dallas
- Thomas KingDallas$12M
- Jennifer ZonDallas$5.9M
- Chrisette DharmagunaratneDallas$5.6M
- Michele ReynoldsDallas$3.8M
- Shiwali RaiDallas$2.8M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.